SMEDI CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 515 KRW | -1.53% |
|
+2.39% | +28.75% |
| Sales 2022 | 19.1B 13.87M | Sales 2023 | 55.75B 40.47M | Capitalization | 57.11B 41.46M |
|---|---|---|---|---|---|
| Net income 2022 | -49.56B -35.98M | Net income 2023 | -14.54B -10.56M | EV / Sales 2022 | 2.58 x |
| Net Debt 2022 | 5.3B 3.85M | Net cash position 2023 | 19.05B 13.83M | EV / Sales 2023 | 0.68 x |
| P/E ratio 2022 |
-0.88
x | P/E ratio 2023 |
-2.9
x | Employees | 22 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 59.09% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.53% | ||
| 1 week | +2.39% | ||
| Current month | -6.70% | ||
| 1 month | -9.17% | ||
| 3 months | +30.05% | ||
| 6 months | +27.16% | ||
| Current year | +28.75% |
1 week
495.00
530.00
1 month
488.00571.00
Current year
377.00571.00
1 year
370.00767.00
3 years
370.002 730.00
5 years
370.006 490.00
10 years
370.0015 300.00
| Managers | Title | Age | Since |
|---|---|---|---|
Beom-Yong Shin
CEO | Chief Executive Officer | 52 | - |
Min-Seo Kim
DFI | Director of Finance/CFO | 47 | - |
Dae-Woo Song
SAM | Sales & Marketing | 48 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jeong-Mi Lee
BRD | Director/Board Member | 48 | - |
Yoon-Cheol Kim
BRD | Director/Board Member | 53 | - |
Beom-Yong Shin
CEO | Chief Executive Officer | 52 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 515 | -1.53% | 188,254 |
| 24-04-23 | 523 | 0.00% | 209,595 |
| 24-04-22 | 523 | +2.35% | 328,682 |
| 24-04-19 | 511 | +0.79% | 184,445 |
| 24-04-18 | 507 | +0.80% | 298,373 |
End-of-day quote Korea S.E., April 23, 2024
More quotes
SMeDi Co Ltd, formerly The MediPharm Co Ltd, is a Korea-based company primarily engaged in the pharmaceutical distribution business. The Company operates through five segments. The Pharmaceuticals Business segment is engaged in the distribution of pharmaceuticals including recapsules and tablets. The Medical Business segment is engaged in the distribution of medical devices and medical supplies. The Wireless Device segment is engaged in the manufacture of wearable wireless devices. The Video Content segment is engaged in the production of video products. The Investment segment is engaged in the management consulting and investment businesses.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +28.75% | 53.44M | |
| +15.65% | 70.36B | |
| +2.72% | 25.18B | |
| +5.13% | 8.61B | |
| +6.10% | 8.14B | |
| -21.85% | 7.83B | |
| +0.73% | 4.56B | |
| +17.40% | 4.32B | |
| -0.14% | 4.06B | |
| -2.34% | 3.87B |
- Stock Market
- Equities
- A118000 Stock
